FMC Corporation CEO Pierre Brondeau discussed a $200 million deal to license an AI-discovered molecule to Corteva. The molecule has a dual mode of action with applications in soybean and corn. The $200 million will support FMC's debt reduction process.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Anterra Capital closes $100M first close for Fund III